July 26, 2024 News by Steve Bryson, PhD Kesimpta outperforms Aubagio among ethnically diverse groups Kesimpta (ofatumumab) is more effective than Aubagio (teriflunomide) among people with multiple sclerosis (MS) from ethnically diverse groups, including Black and African American, Hispanic and Latino, and Asian individuals, according to an analysis of pooled clinical trial data. āDetermining whether there are differences in how people respond…
July 25, 2024 Columns by Benjamin Hofmeister Disability pride is a tricky concept for me to relate to I almost didn’t write this column. It might be a sensitive topic, but I’m not afraid of offending anyone. Even if I do, it’s not intentional. It’s not that I don’t understood the subject, either. I think I do, but I’ve been having a lot of trouble putting it into…
July 25, 2024 News by Katherine Poinsatte, PhD Potential MS therapy IMP761 to be tested in healthy volunteers Immutep has been cleared to start a Phase 1 clinical trial in the Netherlands to test IMP761, its experimental antibody therapy for autoimmune diseases such as multiple sclerosis (MS), in healthy volunteers. The first-in-human Phase 1 clinical trial seeks to assess the safety and pharmacological properties of IMP761.
July 24, 2024 News by Marisa Wexler, MS Machine learning analysis of eye scans may aid diagnosis of MS Using machine learning to analyze eye scans can help detect slight changes that may be early signs of multiple sclerosis (MS), potentially aiding in early diagnosis of the disease, a study found. The study, “SLO-Net: Enhancing Multiple Sclerosis Diagnosis Beyond Optical Coherence Tomography Using Infrared Reflectance…
July 23, 2024 News by Andrea Lobo, PhD Modafinil reduces fatigue, improves quality of life in MS: Analysis Treatment with modafinil, a stimulant approved in the U.S. for treating certain sleep-related disorders, significantly reduced fatigue and improved overall quality of life when used in clinical trials for people with multiple sclerosis (MS), according to a review of published study data. However, its use was linked to a…